| Bettina Wohlforth, AUD | |
|
100 Melrose Ave Ste 108, Greenwich, CT 06830-6277 | |
| (203) 661-7879 | |
| Not Available |
| Full Name | Bettina Wohlforth |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 100 Melrose Ave Ste 108, Greenwich, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114202017 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 171 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Bettina Wohlforth, AUD 100 Melrose Ave Ste 108, Greenwich, CT 06830-6277 Ph: (203) 661-7879 | Bettina Wohlforth, AUD 100 Melrose Ave Ste 108, Greenwich, CT 06830-6277 Ph: (203) 661-7879 |
News Archive
As blood thinners emerge in the market for stroke prevention many experts believe is still too early to predict how they will stack up in the $15 billion a year market.
Preliminary results from the first four brains donated to the Canadian Sports Concussion Project at the Krembil Neuroscience Centre, TorontoWesternHospital, reveal that two of the four former Canadian Football League (CFL) players suffered from a brain disease known as Chronic Traumatic Encephalopathy (CTE), while two did not show signs of CTE.
Sermo, the world's largest online community for physicians, today announced a Sermo Event™ Report titled "Evolving Trends in CML." The new report measures the impact of ENESTnd trial data on Oncologists' use of Tasigna (Novartis), Sprycel (Bristol Myers-Squibb) and Gleevec (Novartis) in newly diagnosed CML patients and assesses overall trends in CML monitoring and management. While Gleevec will likely remain the #1 treatment, there will be a close race for the runner-up spot amongst second-generation tyrosine kinase inhibitors in the front line setting.
US-Australian drug discovery company, Novogen Ltd, and its subsidiary, CanTx, Inc., and Yale University, on March 27 released pre-clinical data on experimental anti-cancer drug, Cantrixil. The data was presented as an oral presentation by Professor Gil Mor MD PhD of Yale Medical School to the 62nd Annual Scientific Meeting of the Society of Reproductive Investigation in San Francisco, CA.
› Verified 8 days ago
Marian Henniges, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 4 Dearfield Dr, Suite 104, Greenwich, CT 06831 Phone: 203-629-5500 | |
Joshua Jablonski, Audiologist Medicare: Accepting Medicare Assignments Practice Location: 49 Lake Ave, Suite 103, Greenwich, CT 06830 Phone: 203-869-2030 | |
Dr. Anne Reap, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 500 W Putnam Ave, Suite 400, Greenwich, CT 06830 Phone: 203-542-7323 Fax: 203-542-7701 | |
Better Hearing At Home Audiologist Medicare: Not Enrolled in Medicare Practice Location: 500 W Putnam Ave, Suite 400, Greenwich, CT 06830 Phone: 203-542-7323 | |
Mrs. Mary C Watts, M.S. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 100 Melrose Ave Ste 108, Greenwich, CT 06830 Phone: 203-629-4327 Fax: 203-629-4326 | |
Incoronata Lileika, M.A., CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 49 Lake Ave, Greenwich, CT 06830 Phone: 203-869-0177 |